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ABSTRACT 
GABAB-receptor (GABABR) mediated inhibition is important in regulating neuronal 
excitability. The paired-pulse transcranial magnetic stimulation (TMS) protocol of long-
interval intracortical inhibition (LICI) likely reflects this GABABergic inhibition. However, 
this view is based on indirect evidence from electromyographic (EMG) studies. Here we 
combined paired-pulse TMS with simultaneous electroencephalography (paired-pulse TMS-
EEG) and pharmacology to directly investigate mechanisms of LICI at the cortical level. We 
tested the effects of a conditioning stimulus (CS100) applied 100ms prior to a test stimulus 
(TS) over primary motor cortex on TS-evoked EEG-potentials (TEPs). Healthy subjects were 
given a single oral dose of baclofen, a GABABR agonist, or diazepam, a positive modulator 
at GABAARs, in a placebo-controlled, pseudo-randomized double-blinded crossover study. 
LICI was quantified as the difference between paired-pulse TEPs (corrected for long-lasting 
EEG responses by the conditioning pulse) minus single-pulse TEPs. LICI at baseline (i.e. pre-
drug intake) was characterized by decreased P25, N45, N100 and P180 and increased P70 
TEP components. Baclofen resulted in a trend towards enhancement of LICI of the N45 and 
N100, and significantly enhanced LICI of the P180. In contrast, diazepam consistently 
suppressed LICI of late potentials (i.e. N100, P180), without having an effect on LICI of 
earlier (i.e. P25, N45 and P70) potentials. These findings demonstrate for the first time 
directly at the system level of the human cortex that GABABR-mediated cortical inhibition 
contributes to LICI, while GABAAR-mediated inhibition occludes LICI. Paired-pulse TMS-
EEG allows investigating cortical GABABR-mediated inhibition more directly and 
specifically than hitherto possible, and may thus inform on network abnormalities caused by 
disordered inhibition, e.g. in patients with schizophrenia or epilepsy. 
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1. Introduction
Inhibitory neurotransmission mediated by γ-aminobutyric acid (GABA)-receptors is critical 
for physiological function of the cerebral cortex. Paired-pulse transcranial magnetic 
stimulation (TMS) offers the possibility to study GABAergic inhibition non-invasively in 
humans. The application of a conditioning stimulus 50-200ms prior to a test stimulus (TS) 
over the primary motor cortex (M1) suppresses the test motor evoked potential (MEP) in the 
target muscle with respect to an unconditioned MEP (Valls-Sole et al., 1992). This 
phenomenon is known as long-interval intracortical inhibition (LICI) and was shown to be 
associated with activation of GABAB-receptors (GABABRs) (McDonnell et al., 2006; 
Müller-Dahlhaus et al., 2008). The notion that LICI reflects GABABR-mediated inhibition is 
further supported by studies demonstrating that LICI suppresses GABAA-receptor 
(GABAAR)-mediated cortical inhibition [SICI: short-interval intracortical inhibition (Kujirai 
et al., 1993; Peurala et al., 2008; Ziemann et al., 1996a)], likely through activation of auto-
inhibitory pre-synaptic GABABRs (Daskalakis et al., 2002; Sanger et al., 2001), in line with 
cellular experiments (Davies et al., 1990). However, evidence on the mechanisms of LICI is 
only indirect as it is derived from EMG recordings, which limits its potential as a diagnostic 
tool in a clinical setting. 
Recently, first studies using a combination of TMS and electroencephalography (TMS-
EEG) have started to directly investigate mechanisms of LICI at the cortical level (Daskalakis 
et al., 2008; Farzan et al., 2010; Fitzgerald et al., 2009; Rogasch et al., 2013). It was shown 
that a conditioning stimulus (LICI protocol) induced a reduction of the averaged TS-evoked 
EEG potential (TEP) recorded at the C3 electrode, which is located above the stimulated M1 
(Daskalakis et al., 2008; Farzan et al., 2010; Fitzgerald et al., 2009; Rogasch et al., 2013). 
However, the physiological underpinnings and spatiotemporal characteristics of this effect 
remained unexplored. 
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By combining high-density TMS-EEG with pharmacology we were recently able to 
demonstrate (Premoli et al., 2014) that specific components of (single-pulse) TEPs, i.e. the 
negative potentials at around 45 (N45) and 100 (N100) milliseconds post stimulus (Lioumis et 
al., 2009; Rogasch et al., 2013), can be linked to GABAAR- and GABABR-mediated 
neurotransmission, respectively. In the current study, we extend these studies by applying 
paired-pulse TMS-EEG and pharmacology to characterize and study the spatiotemporal 
dynamics of LICI directly at the level of the cortex. Subjects received a single oral dose of 
placebo, baclofen (i.e., GABABR agonist), or diazepam (i.e., benzodiazepine and allosteric 
positive modulator of α1, α2, α3 and α5 subunit bearing GABAARs) in a randomized, 
placebo-controlled double-blinded crossover study. LICI was quantified as the difference 
between paired-pulse TEPs (corrected for long-lasting EEG responses by the conditioning 
pulse) minus single-pulse TEPs. LICI at baseline (i.e. pre-drug intake) was characterized by 
decreased P25, N45, N100 and P180 and increased P70 TEP components. Baclofen showed a 
trend towards enhancement of LICI of the N45 and N100, and significantly enhanced LICI of 
the P180. In contrast, diazepam consistently suppressed LICI of later potentials (i.e. N100, 
P180), without having an effect on LICI of earlier (i.e. P25, N45 and P70) potentials. Our data 
thus provide, for the first time, novel evidence at the cortical level that LICI reflects 
GABABR-mediated inhibition and suggest a tight control of GABABR-mediated inhibition 
by GABAAergic neurotransmission. 
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2. Material and Methods
2.1 Subjects 
Nineteen male subjects aged 22-32 years (mean age, 26.4 ± 3.5 years) participated in this 
study after having given written informed consent. Female participants were excluded due to 
menstrual cycle related effects on cortical excitability, which can be a potential confound in 
TMS studies (Smith et al., 1999). All subjects were right-handed according to the Edinburgh 
Handedness Inventory (laterality score ≥75%) (Oldfield, 1971). Subjects underwent a 
physical examination before each experiment and were screened for contraindications to TMS 
(Rossi et al., 2009). Exclusion criteria included the presence of a history of neurological or 
psychiatric disease, use of CNS active drugs, abuse of any drugs (including nicotine and 
alcohol) or contraindications to the study medications (baclofen and diazepam). All subjects 
were naïve to the study medication. The study was approved by the local Ethics Committee of 
the Medical Faculty of the Eberhard-Karls University Tübingen, Germany. 
2.2 Experimental design 
Subjects participated in three pseudo-randomized experimental sessions, which were 
separated by at least one week to exclude carry-over effects. Subjects received either a single 
oral dose of baclofen (50mg Lioresal®, Novartis Pharma), diazepam (20mg Diazepam-
ratiopharm®, ratiopharm GmbH), or placebo (P-Tabletten Lichtenstein). Baclofen is a 
specific GABABR agonist, while diazepam is a classical benzodiazepine binding at α1, α2, α3 
and α5 subunit containing GABAARs. Drug doses and time points of post-drug 
measurements were chosen according to previous experiments that reported a significant 
modulation of TMS-EMG and TMS-EEG parameters for motor cortical inhibition 90 minutes 
after drug intake (Müller-Dahlhaus et al., 2008; Premoli et al., 2014), and in line with 
pharmacokinetic studies showing peak plasma concentrations 90 minutes after drug intake 
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(McDonnell et al., 2006; Shader et al., 1984). Thus, TMS-EEG recordings were conducted at 
baseline and 90 minutes after drug intake. 
2.3 Transcranial magnetic stimulation (TMS) and electromyography (EMG) 
Focal TMS of the hand area of left primary motor cortex (M1) was performed with a figure-
of-eight coil (external diameter of each wing, 90mm) connected to a Magstim 200
2
 magnetic
stimulator (Magstim Company, Carmarthenshire, Wales, UK) with a monophasic current 
waveform. The optimal coil position over the hand area of left M1 for eliciting MEPs in the 
right abductor pollicis brevis muscle (APB) was determined as the site where TMS at a 
slightly suprathreshold intensity consistently produced the largest MEPs. MEP recordings 
were obtained by surface electromyography (EMG), using Ag-AgCl cup electrodes in a belly–
tendon montage. The EMG raw signal was amplified and band-pass filtered (20Hz to 2kHz; 
D360 amplifier, Digitimer, Hertfordshire, UK) and digitized at an A/D rate of 10kHz per 
channel (CED Micro 1401; Cambridge Electronic Design, Cambridge, UK). The coil was 
held tangential to the scalp with the handle pointing backwards and 45 degrees away from the 
midline, thus activating the corticospinal system preferentially trans-synaptically via 
horizontal cortico-cortical connections (Di Lazzaro et al., 2008). Resting motor threshold 
(RMT) was determined using the relative frequency method (Groppa et al., 2012) and was 
defined as the minimum intensity (as a percentage of the maximum stimulator output [MSO]) 
that was sufficient to elicit MEPs larger than 50µV peak-to-peak amplitude in at least five out 
of ten subsequent trials. The position of the APB hotspot was marked with a felt pen on the 
EEG cap to ensure constant coil placement throughout the experiment. 
Paired-pulse TMS to test LICI was applied according to an established protocol (Valls-
Sole et al., 1992), consisting of a conditioning stimulus applied 100ms (CS100) before delivery 
of a TS. Stimulus intensities for CS100 and TS were 100% RMT in order to limit re-afferent 
somatosensory feedback, which can contaminate the EEG signal (Paus et al., 2001). During 
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the EEG registration 125 randomly intermixed single and paired TMS pulses each were 
applied over the left M1 APB hotspot at an inter-trial interval (ITI) of 5s on average (random 
ITI variation of 25% in order to reduce anticipation of the next trial). 
2.4 High-density electroencephalography (EEG) recordings during TMS 
TMS-evoked EEG potentials were recorded using a TMS-compatible EEG system (BrainAmp 
DC, BrainProducts GmbH, Munich, Germany), which prevents EEG amplifier saturation and 
allows continuous data recording during TMS. The EEG signal was digitized at a sampling 
frequency of 5kHz and continuously recorded by 62 electrodes mounted on an elastic cap 
according to the standard layout (BrainCap-Fast’n Easy 64Ch, Brain Products GmbH). 
Horizontal eye movements were recorded by placing an electrode outside the outer canthus of 
the eye, while an electrode placed below the right eye recorded vertical eye movements and 
blinks. The impedance of all electrodes was kept <5kΩ throughout the experiment. 
During the TMS-EEG recordings subjects were seated in a comfortable reclining chair 
and were asked to stay awake with eyes open. To avoid contamination of the EEG signal by 
auditory potentials evoked by the click associated with current discharge through the TMS 
coil, a masking noise was applied to both ears by earphones (Massimini et al., 2005). 
2.5 Data processing and analysis 
EEG data preprocessing and TEP analysis were performed using the Fieldtrip open source 
MATLAB toolbox (www.ru.nl/fcdonders/fieldtrip/) (Oostenveld et al., 2011). The EEG signal 
was first re-referenced to the linked mastoids (channels TP9 and TP10) and down-sampled to 
1kHz. Single- and paired-pulse trials were defined from continuously recorded EEG time 
series and segmented with respect to the TS and CS, respectively, such that each epoch 
included a 500ms pre-stimulus baseline and a 600ms post-stimulus recording. TMS artifacts 
(by single- and paired-pulses) were removed by applying a linear interpolation for 10ms 
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before and after the TMS pulses (Thut et al., 2011). Thereafter, each trial was linearly 
detrended and band-pass filtered between 2 and 80Hz. A 50Hz notch filter was applied to 
reduce line noise contamination. EEG trials were visually scrutinized and trials containing 
artifacts due to, e.g., eye movements or muscle activation were eliminated. The data from four 
subjects had to be excluded from final analysis because of excessive artifact contamination of 
the EEG traces. Thus, data reported was analyzed from 15 subjects. 
Artifact-free EEG trials from 62 channels (see above) for single (averaged number of 
trials across subjects ± SEM before and after diazepam: 107 ± 3 and 99 ± 3; baclofen: 109 ± 3 
and 108 ± 3; placebo: 104 ± 3 and 107 ± 4) and paired (averaged number of trials across 
subjects before and after diazepam: 105 ± 3 and 95 ± 3; baclofen: 110 ± 3 and 105 ± 4; 
placebo: 104 ± 3 and 105 ± 4) TMS pulses were baseline corrected by subtracting the mean 
amplitude during an interval between -500ms and -150ms before TMS onset (i.e. before CS 
[paired-pulse condition] and TS alone [single-pulse condition], respectively).  
When registering EEG responses during paired-pulse TMS, a serious confound is the 
effect of late (i.e. > 100 ms) EEG responses evoked by CS100, which superimpose early EEG 
responses evoked by TS (Daskalakis et al., 2008). To correct for such late CS100-induced EEG 
responses we used a subtraction method: the average cortical evoked potential elicited by the 
TS alone (single-pulse TMS trials; Figure 1A), aligned to CS100 onset, was subtracted from 
the average cortical evoked potential elicited by the CS100-TS pulse pair (Figure 1B) 
[(Daskalakis et al., 2008); paired-pulse corrected, Figure 1C]. To determine LICI, we then 
subtracted the average single-pulse TEP, aligned to TS onset, from the paired-pulse corrected 
TEP (Figure 1D). This procedure is justified, as both CS and TS intensity equaled 
100%RMT. Throughout this work, TEPs elicited by paired-pulse TMS will refer to evoked 
potentials corrected for late EEG responses of CS100 (Figure 1B), while LICI will refer to the 
difference between single-pulse and paired-pulse corrected TEPs (Figure 1D). 
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Single and paired-pulse TEPs were calculated by averaging the EEG signal over all 
retained trials for each channel. In order to smooth the TEP, we filtered the data between 1 
and 45 Hz. In accordance with the literature (Lioumis et al., 2009; Premoli et al., 2014), five 
TEP components were considered (non-overlapping time windows of interest [TOI] given in 
brackets; P, positive deflection; N, negative deflection): P25 (17 - 37 ms), N45 (38 - 57 ms), 
P70 (58 - 84 ms), N100 (85 - 150 ms) and P180 (160 - 230 ms) (Figure 2A). TOIs were 
chosen on the basis of the grand average of single- and paired-pulse TEPs, and were equal in 
both TMS (i.e., single- and paired-pulse) and across drug conditions. To evaluate the cortical 
effects of LICI, single- versus paired-pulse corrected TEPs were contrasted as described 
above for all TEP components. The effects of diazepam and baclofen, respectively, on LICI 
were investigated by evaluating changes of LICI between post- and pre-drug conditions for all 
TEP components. 
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Figure 1. Determination of the EEG signature of long-interval intracortical inhibition 
(LICI). 
Paired-pulse TEPs (B) were corrected for late (>100ms) CS-evoked EEG responses, which 
overlap with early TS-evoked EEG potentials in the paired pulse condition, by subtracting 
EEG responses evoked by TS alone (A) from paired-pulse TEPs (B) aligned to the time of CS 
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(paired-pulse corrected TEPs, C). The effect of CS on TS-evoked TEPs, i.e. LICI (D), was 
obtained by subtracting single-pulse TEPs (A) from paired-pulse corrected TEPs (C) aligned 
to the time of TS. Note that both CS and TS were delivered at an intensity of 100% RMT, 
justifying this approach. Data are grand-averaged over all channels and the three drug 
conditions at baseline (i.e. before drug intake). Vertical dashed lines indicate times of TMS 
pulses. The shaded grey bars depict the part of the EEG trace (± 10ms), which was linearly 
interpolated to remove TMS-induced artifacts. 
2.6 Statistics 
To assess whether RMT measurements were consistent and reproducible at baseline across 
the three drug conditions a one way repeated measures ANOVA with the within-subject factor 
DRUG (3 levels: diazepam, baclofen and placebo) was employed. Cronbach’s alpha was used 
to assess test-retest reliability for every TEP component of single- and paired-pulse TEPs, 
respectively. 
To analyze (i) LICI and (ii) drug-induced changes in LICI, multiple dependent sample t-
tests [(i) paired- vs. single-pulse; (ii) LICI post- vs. LICI pre-drug intake] were separately 
applied for the different conditions and TOIs. To correct for multiple comparisons, we 
adopted a cluster based permutation analysis (Maris and Oostenveld, 2007) as implemented in 
FieldTrip (http://fieldtrip.fcdonders.nl/). That is, a paired t-test comparing the different 
conditions was performed for each electrode at each time bin within the five different TOIs. 
T-values exceeding an a priori threshold of p < 0.01 were clustered based on adjacent time 
bins and neighboring electrodes. Cluster-level statistics were calculated by taking the sum of 
the t-values within every cluster. The statistical comparisons were done with respect to the 
maximum values of summed t-values. By means of a permutation test, i.e. randomizing data 
across (i) paired vs. single-pulse and (ii) LICI post- vs. LICI pre-drug conditions and 
rerunning the statistical test 1500 times, we obtained a reference distribution of the maximum 
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of summed cluster t-values to evaluate the statistic of the actual data. Clusters in the original 
data set were considered to be significant at an α­level of 5% if less than 5% of the 
permutations used to construct the reference distribution yielded a maximum cluster-level 
statistic larger than the cluster-level value observed in the original data. The reported p-values 
were further Bonferroni-corrected for TOIs (n = 5) and conditions (n = 2) [(i) paired vs. 
single-pulse; (ii) post- vs. pre-drug], which is reflected by a corrected alpha-value of α = 
0.05/10. All data are presented as means ± SEM if not indicated otherwise. 
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3. Results
Experimental procedures and study drugs were generally well tolerated except for mild to 
moderate sedation and dizziness, which did not affect the capability of the subjects to fully 
comply with the requirements of this study. Part of the data from the single-pulse TMS trials 
has been published previously (cf. Experiment 2 in Premoli et al., 2014). 
3.1 Differences between paired- and single-pulse TMS-evoked potentials (TEPs) before 
drug intake (LICI at baseline) 
First, we evaluated reliability of single-pulse TEPs, and the difference between paired- and 
single-pulse TEPs (i.e., LICI; cf. Material and Methods, Fig. 1), at baseline, i.e. pre-drug 
intake. Grand averages of single-pulse TEPs and LICI were calculated separately for the three 
pre-drug conditions (Figure 2A-B). The amplitudes of the single-pulse P25, N45, P70, N100 
and P180 TEP components, and LICI of these TEP components, were then extracted from the 
grand averages of all channels, for each subject. Cronbach’s alpha values > 0.7 (Farzan et al., 
2010; Neuper et al., 2005) revealed a high level of reproducibility for all single-pulse TEPs 
and LICI of TEP components across drug conditions (Figures 2C-D), except for LICI of the 
P25 which showed a low level of reliability (Cronbach’s alpha values < 0.7). RMT was not 
significantly different between drug conditions at baseline before drug intake (diazepam: 44.6 
± 1.3% MSO; baclofen: 44.1 ± 1.3% MSO; placebo: 44.8 ± 1.2% MSO; F(2,28)= 1.12, p = 
0.34) and thus cannot account for any of the observed drug-induced changes of LICI (see 
below). 
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Figure 2. Reproducibility Test-retest reliability of single-pulse TEPs and LICI (paired- 
minus single-pulse TEPs) at baseline before drug intake. 
Grand-average (over all electrodes and artifact-free trials) of single-pulse TEPs (A) and LICI 
(paired- minus single-pulse TEPs; B) calculated separately before intake of diazepam (blue 
line), baclofen (red line) and placebo (black line). Vertical dashed lines indicate times of TMS 
pulses. The shaded grey bars depict the part of the EEG trace (± 10ms), which was linearly 
interpolated to remove TMS-induced artifacts. (C and D) Histograms illustrate reproducibility 
(i.e. test-retest reliability) of single-pulse TEPs (C) and LICI (D) across drug conditions at 
baseline for each TEP and LICI component (i.e. P25, N45, P70, N100 and P180 amplitudes), 
respectively. Cronbach’s alpha > 0.70 indicates a high level of reliability across drug 
conditions at baseline. 
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As previously described by our group (Premoli et al., 2014), the grand-average EEG 
response evoked by single-pulse TMS of the left M1 is characterized by the most prominent 
TEP components P25, N45, P70, N100 and P180, each with a distinct topographical 
distribution (Figure 3A-B). Compared to single-pulse TEPs, topographical surface voltage 
maps of paired-pulse TEPs (Figure 3A,C) showed a marked reduction of all TEP components 
except for the P70, which was significantly increased in the stimulated hemisphere. 
Quantification of LICI, i.e. the difference paired- minus single-pulse TEPs (Figure 3D), by 
means of a non-parametric, cluster-corrected permutation analysis in 5 non-overlapping TOIs 
showed that the amplitudes of the P25 (single-pulse: 3.8 ± 0.6μV, paired-pulse: 2.4 ± 0.5μV; 
p = 0.003), N45 (single-pulse: -2.2 ± 0.4μV, paired-pulse: -1.7 ± 0.4μV; p = 0.004), N100 
(single-pulse: -3.2 ± 0.5μV, paired-pulse: -1.1 ± 0.3μV; p = 0.002) and P180 (single-pulse: 
2.4 ± 0.4μV, paired-pulse: 1.2 ± 0.2μV; p = 0.004) potentials were significantly reduced. In 
contrast, the amplitude of the P70 potential was significantly increased in the paired- vs. 
single-pulse TMS condition (single-pulse: 2.3 ± 0.7μV, paired-pulse: 3.4 ± 0.7μV; p = 0.004) 
(Figure 3A, F). Topographical plots of LICI showed that modulation of single-pulse TEPs by 
CS100 was expressed at the site of the TEP components (Figure 3E). 
Investigation of LICI at the level of individual subjects revealed that most of the 
subjects showed a decrease in P25, N45, N100 and P180 potentials, and an increase in the P70 
potential, in the paired- vs. single-pulse TMS condition, but few subjects showed opposite 
effects compared to the group on average (Figure 4). 
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Figure 3. Spatiotemporal expression of LICI at baseline before drug intake. 
(A) Grand-averaged TEPs at baseline before drug intake (over all electrodes, artifact-free 
trials and drug conditions) induced by left M1 single- (blue) and paired- (red) pulse 
stimulation. Note that TS-evoked EEG responses in the paired-pulse condition were corrected 
for late (i.e. >100ms) CS-evoked EEG responses (cf. Fig. 1C and section 2.5). The vertical 
dashed lines indicate the times of CS (paired-pulse TMS) and TS (single- and paired-pulse 
TMS), respectively. The shaded grey bars depict the parts of the EEG trace (± 10ms), which 
were linearly interpolated to remove the TMS-induced artifacts. Blue and red shades represent 
± 1 SEM of grand-averaged TEP curves. (B) and (C) illustrate topographical distributions of 
surface voltages for the most pronounced TEP components (P25, N45, P70, N100, P180; 
grand-average over all drug conditions) elicited by single- (B) and paired- (C) pulse 
stimulation. Maps are scaled and color-coded individually according to their respective 
maximum (red) and minimum (blue) voltages. (D) LICI (grand-averaged over all drug 
conditions) as determined by subtraction of paired- minus single-pulse TEPs (cf. Fig. 1D). 
The grey shade represents ± 1 SEM. (E) illustrates the topographical distribution of LICI for 
each TEP component, whilst (F) shows t-statistic maps of TEP amplitude differences (paired- 
minus single-pulse TEPs) for these components (P25, N45, P70, N100, P180). Asterisks in (F) 
indicate channels, which showed significant differences between paired- and single-pulse TEP 
amplitudes. Blue colors indicate a decrease in positivity, while red colors reflect either a 
decrease in negativity or an increase in positivity. 
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Figure 4. LICI at baseline before drug intake (single subject data). 
Scatter plot of individual LICI of TEP components, i.e. amplitude modulations of the P25, 
N45, P70, N100 and P180 potentials by CS100 (paired- minus single-pulse TEPs, cf. Fig. 3D) 
at baseline before drug intake. For each TEP component amplitudes were extracted from 
those channels showing a significant difference between the paired- and single-pulse 
condition (cf. Fig. 3F). Each subject is represented by a specific shape and color. Horizontal 
bars represent group averages ± 1 SEM. Note that positive values for the negative TEP 
components (N45, N100) indicate a decrease in negativity in the paired- vs. single-pulse 
condition. 
As we have shown previously, the N100 component of single-pulse TEPs reflects 
GABABR-mediated neurotransmission (Premoli et al., 2014). Thus, the TS in the paired-
pulse condition was delivered at a time of (CS100-induced) enhanced GABABR activity. LICI 
of the P25 (i.e. the averaged difference paired- minus single-pulse TEP amplitudes over 
channels which showed significant modulation of the P25, cf. Fig. 3F) correlated directly with 
the N100 amplitude in the single-pulse condition (Spearman correlation, r
2 
= 0.34, p = 0.02,
data extracted from those channels which were significantly modulated by baclofen, cf. Fig. 
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7C, Premoli et al., 2014) (Figure 5), suggesting that LICI of the P25 was GABABR-
mediated. In contrast, none of the CS100-induced modulations of any of the other TEP 
components correlated with the N100 amplitude in the single-pulse condition (p > 0.05). 
Figure 5. Correlation between LICI of the P25 TEP component and single-pulse N100 
amplitude.  
A significant positive correlation (Spearman correlation, r
2 
= 0.34, p= 0.02) was found
between suppression of the P25 amplitude by CS100 in the paired-pulse condition (paired- 
minus single-pulse TEP amplitude, i.e. LICI; x-axis) and the N100 amplitude in the single-
pulse condition as an index of GABABR-mediated inhibition (y-axis; extracted from the 
channels which were significantly modulated by baclofen, cf. Fig. 7C, Premoli et al., 2014).  
3.2 Modulation of LICI by diazepam and baclofen 
To evaluate drug effects on LICI (i.e. the difference between paired- minus single-pulse 
TEPs), we compared LICI post- vs. pre-drug by using a cluster-based permutation analysis 
(computed over all channels) in the 5 non-overlapping TOIs, corresponding to the P25, N45, 
P70, N100 and P180 potentials. Diazepam occluded LICI of the N100 over contralateral, 
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fronto-central sites (pre: 1.4 ± 0.3 μV, post: 0.1 ± 0.2μV; average over channels significantly 
modulated by diazepam [cf. Fig. 6D], p = 0.003) and even turned LICI of the P180 into 
facilitation over central areas (pre: -0.4 ± 0.3μV, post: 0.8 ± 0.2μV; average over channels 
significantly modulated by diazepam [cf. Fig. 6D], p = 0.003) (Figure 6A-D). In contrast, the 
GABABR agonist baclofen showed a trend towards a significant enhancement of LICI of the 
N45 in the contralateral (pre: 0.2 ± 0.3μV, post: 0.7 ± 0.2μV; average over channels 
significantly modulated by baclofen [cf. Fig. 7D], p = 0.01) and of LICI of the N100 in the 
ipsilateral hemisphere (pre: -0.9 ± 0.5μV, post: 0.2 ± 0.6μV; average over channels 
significantly modulated by baclofen [cf. Fig. 7D], p = 0.009). Baclofen significantly increased 
LICI of the P180 in frontal and right-central regions (pre: -0.5 ± 0.3μV, post: -1.3 ± 0.3μV; 
average over channels significantly modulated by baclofen [cf. Fig. 7D], p = 0.001) (Figure 
7A-D). There were no significant differences pre vs. post placebo in any of the five TOIs (p > 
0.005, corrected for multiple comparisons; data not shown). 
For diazepam, these results were confirmed by a cluster-corrected analysis between 
post-drug conditions. Compared to placebo, diazepam showed a trend towards a decrease of 
LICI of the N100 (p = 0.01, channels significantly modulated: 'C4', 'C6', 'CP4', 'CP6' and 
'TP8') and a decrease of LICI of the P180 (p = 0.001, channels significantly modulated: 'FT7', 
'F7', 'F5', 'F3', 'F1', 'Fz', 'FC5', 'FC3', 'FC1', 'FC2', 'C1', 'Cz', 'C2', 'C4', 'CP2' and 'CPz'). In 
contrast, post-drug comparisons between baclofen and placebo did not show any significant 
differences (p > 0.005, corrected for multiple comparisons). 
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Figure 6. Diazepam effects on LICI. 
LICI (i.e., paired- minus single-pulse TEPs, cf. Fig. 3D) was obtained before (Pre, blue) and 
after (Post, red) intake of diazepam (A). LICI curves are averaged across channels, which 
showed significant drug-induced effects as indicated by asterisks in (D). (B-C) Topography of 
LICI before (B) and after (C) diazepam intake. Blue colors indicate a decrease in positivity, 
while red colors reflect either a decrease in negativity or an increase in positivity. Black bars 
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in (A) represent TOIs of significant drug-induced changes in LICI corresponding to the N100 
and P180 potentials. Plots in (D) show t-statistic maps of drug-induced changes in LICI (post- 
minus pre-drug intake) for the N100 and P180 TEP components. Red indicates a decrease of 
‘negative’ LICI (i.e. the suppressive effect of CS100 on P180 was decreased by diazepam), 
whilst blue indicates a decrease of ‘positive’ LICI (i.e. the suppressive effect of CS100 on 
N100 is decreased by diazepam). Note that diazepam suppressed LICI of the N100 and P180 
potentials. 
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Figure 7. Baclofen effects on LICI. 
LICI (i.e. paired- minus single-pulse TEPs, cf. Fig. 3D) was obtained before (Pre, blue) and 
after (Post, red) intake of baclofen (A). LICI curves are averaged across channels, which 
showed significant drug-induced effects as indicated by asterisks in (D). Topography of LICI 
before (B) and after (C) baclofen intake. Blue colors indicate a decrease in positivity, while 
red colors reflect either a decrease in negativity or an increase in positivity. Black bars in (A) 
represent TOIs of significant drug-induced changes in LICI corresponding to the N45, N100 
and P180 potentials. Plots in (D) show t-statistic maps of drug-induced changes in LICI (post- 
minus pre-drug intake) for the N45, N100 and P180 TEP components. Red indicates an 
increase of ‘positive’ LICI (i.e. the suppressive effect of CS100 on N45 and N100 were 
enhanced by baclofen), whilst blue indicates an increase of ‘negative’ LICI (i.e. the 
suppressive effects of CS100 on P180 were enhanced by baclofen). 
Investigation of drug-induced changes in LICI at the level of individual subjects 
revealed moderate inter-individual variability with most of the subjects showing a suppression 
of LICI of the N100 and P180 potentials after diazepam intake (Figure 8A), and an 
enhancement of LICI of the N45, N100 and P180 potentials after baclofen intake (Figure 
8B), but some subjects showed opposite effects as the group on average. 
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Figure 8. Drug effects on LICI (single subject data). 
Scatter plots of diazepam (A) and baclofen (B) effects on LICI (post minus pre drug intake) of 
the significant TEP components (A: N100 and P180; B: N45, N100 and P180; cf. Fig. 6 and 
7). LICI was extracted from those channels, which were significantly modulated by diazepam 
(cf. Fig. 6D) and baclofen (cf. Fig. 7D), respectively. Each subject is represented by a specific 
shape and color. Horizontal bars represent group average ± 1 SEM. 
3.3 Relationship between LICI at baseline and drug-induced changes of LICI 
To further investigate the cortical mechanisms of LICI, we performed correlation analyses 
between LICI and drug-induced changes of LICI. For diazepam we found a significant 
inverse correlation between LICI of the N100 (Figure 9A) and P180 (Figure 9B) at baseline 
and the diazepam-induced change in LICI of these potentials (Spearman r
2 
= 0.3, p = 0.03 and
Spearman r
2 
= 0.8, p < 0.001, respectively), indicating that the diazepam-induced suppression
of LICI of the N100 and P180 was highest in those individuals who showed the highest LICI 
of these potentials at baseline. In contrast, for baclofen we did not find significant correlations 
between LICI of the N45, N100 or P180 at baseline and the baclofen-induced change in LICI 
of these potentials (Spearman correlation, p > 0.05), suggesting independent underlying 
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mechanisms. In line with this notion, LICI of the N100 was expressed over the right 
hemisphere (i.e. contralateral to the stimulation; cf. Fig. 3E-F), whereas the baclofen-induced 
increase in LICI of the N100 was expressed ipsilateral to the stimulation (cf. Fig. 7D). 
Figure 9. Correlation between LICI of the N100 and P180 potentials (at baseline) and 
the diazepam-induced change in LICI of these potentials. 
(A) A significant inverse correlation was found between suppression of the N100 amplitude 
by CS100 in the paired-pulse condition (i.e. LICI of the N100; x-axis; data averaged across 
channels, which showed significant LICI of the N100, cf. Fig. 3F) and the diazepam-induced 
suppression of LICI of the N100 potential (y-axis; data averaged across channels, which 
showed significant diazepam-induced changes of LICI of the N100, cf. Fig. 6D). (B) A 
significant inverse correlation was found between suppression of the P180 amplitude by CS100 
in the paired-pulse condition (i.e. LICI of the P180; x-axis; data averaged across channels, 
which showed significant LICI of the P180, cf. Fig. 3F) and the diazepam-induced 
suppression of LICI of the P180 potential (y-axis; data averaged across channels, which 
showed significant diazepam-induced changes of LICI of the P180, cf. Fig. 6D). 
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4. Discussion
In this study, by applying paired-pulse TMS (LICI protocol) in conjunction with simultaneous 
high-density EEG and pharmacology we provide novel evidence for inhibitory 
neurotransmission mediated by GABABRs in the human cortex. 
4.1 EEG signatures of LICI at baseline (comparison between paired- and single-pulse 
TEPs) 
Evidence from TMS-EMG experiments suggests that whilst LICI at short interstimulus 
intervals (ISI) of around 50ms may include spinal inhibitory mechanisms, LICI at longer ISIs 
of 100-200ms is predominantly cortical in nature (Di Lazzaro et al., 2002; Nakamura et al., 
1997). Pharmacological studies further showed that LICI at an ISI of 100ms is associated with 
GABABR-activity (McDonnell et al., 2006; Müller-Dahlhaus et al., 2008). This notion is 
supported by the finding that SICI, another paired-pulse TMS paradigm likely representing 
GABAAR-mediated inhibition (Di Lazzaro et al., 2000; Di Lazzaro et al., 1998; Ilic et al., 
2002; Kujirai et al., 1993; Peurala et al., 2008; Ziemann et al., 1996a, b) is suppressed in the 
presence of LICI, which is thought to derive from activation of presynaptic GABABRs (Cash 
et al., 2010; Müller-Dahlhaus et al., 2008; Sanger et al., 2001). In this study, LICI (quantified 
as paired- minus single-pulse TEPs) showed a suppression of the P25, N45, N100 and P180 
potentials, whereas the P70 was increased (cf. Fig.3). 
Importantly, paired-pulse TEPs (i.e. TS-evoked potentials recorded in the presence of 
CS100) were corrected for long-lasting (i.e. >100ms) EEG responses evoked by CS100 alone 
(cf. Fig.1) by subtracting TEPs evoked by an unconditioned single pulse (TS alone) from 
TEPs evoked by the pulse pair CS100-TS, aligned to CS100 [see Material and Methods, and 
Fig.1C, paired-pulse corrected TEPs]. However, this subtraction does not take into account a 
possible modulation of late (i.e. >100ms) CS100-evoked EEG responses by TS in the paired-
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pulse condition. Thus, in turn, LICI, which was calculated by subtraction of TEPs evoked by 
an unconditioned single pulse (TS alone) from the paired-pulse corrected TEPs, aligned to TS 
[see Material and Methods, and Fig.1D, LICI] may also reflect this TSCS100 interaction in 
addition to the CS100TS interaction. In other words, LICI represents the superimposition of 
CS100-induced modulation of TS-evoked TEPs (the “pure” LICI we want to study) and a 
putative TS-induced modulation of CS100-evoked late (i.e. >100ms) TEP components. 
Unfortunately, there is no way to disentangle these two interactions. To determine the 
TSCS100 interaction, it needs a CS100, which impacts on the subsequent TS (interaction 
CS100TS). Thus, the interaction TSCS100 cannot be studied without a concurrent 
interaction CS100TS, and vice versa. Therefore LICI will always represent a 
superimposition of CS100-induced modulation of TS-evoked TEPs and a possible modulation 
of late CS100-evoked TEP components by a CS100-modulated TS. Of note, this line of 
arguments also applies to LICI as obtained by TMS-EMG: the MEP inhibition is a result of 
this putatively bidirectional interaction of late CS100 effects and TS effects in the stimulated 
cortex.   
Prior studies from our group indicated that the N100 potential reflects GABABR-
mediated inhibition as it is selectively enhanced at the site of the stimulated M1 after intake of 
baclofen (Premoli et al., 2014). Thus, TS in the paired-pulse TMS condition in the present 
study was delivered at a time of increased GABABR-mediated inhibition in the stimulated 
cortex. Accordingly, LICI of the P25 correlated directly with the amplitude of the N100 
potential in the single-pulse condition (cf. Fig.5). As the P25 potential is linked to the MEP 
amplitude elicited in the target muscle (Ferreri et al., 2011; Mäki and Ilmoniemi, 2010), LICI 
of the P25 may represent a marker of GABABergic inhibition of cortico-spinal neurons in the 
stimulated M1. Of note, this effect was present in all subjects tested (cf. Fig.4 and 5), whereas 
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LICI of later TEP components (i.e., N45, P70, N100, P180) showed higher inter-individual 
variability with some subjects showing opposite LICI effects as the group on average. 
Topographical plots of LICI of later TEP components (i.e. N45, P70, N100, P180) 
demonstrated that it was expressed at the same sites as these potentials in the single-pulse 
condition (cf. Fig. 3E). These data suggest that LICI not only inhibits cortico-spinal 
excitability as reflected by a reduction of the P25 potential (see above), but also inhibits the 
cortico-cortical (incl. cortico-thalamo-cortical) spread of evoked neural activity, especially to 
the contralateral hemisphere. In contrast, LICI increased the P70 ipsilaterally to the 
stimulation. The reason for this effect is unclear, but may involve arrival of re-afferent or 
cutaneous sensory potentials from TMS-evoked finger movement as the underlying drivers of 
the P70 (Paus et al., 2001; Rogasch et al., 2013) in a disinhibited cortex in the stimulated 
hemisphere at around 160-180ms after CS100. TMS-EMG experiments demonstrated a late 
cortical disinhibition at CS-TS intervals of around 180ms (Cash et al., 2010; Cash et al., 
2011). 
Our results are in general agreement with a previous study (Fitzgerald et al., 2009), 
which found long-lasting suppression of paired-pulse TEPs at an ISI of 100ms at the 
stimulation site (i.e. the C3 electrode over the stimulated M1). However, this study used a 
time-integrated measure of the mean TS-evoked EEG activity (i.e. the area under the rectified 
TEP curve) and paired-pulse TEPs were not corrected for long-lasting EEG effects of CS. 
More recent work from the same group focused on single TEP components and showed a 
differential modulation of early (P30, P60) and late (N100) potentials as a function of both CS 
and TS intensities (Rogasch et al., 2013). However, either CS or TS were given at an intensity 
to yield, on average, 1mV MEPs in the target small hand muscle when given alone. In 
contrast, in our study we applied both CS and TS at an intensity of 100% RMT and corrected 
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for long-lasting EEG effects of CS (cf. Fig.1 and see Material and Methods). Despite these 
methodological differences both the previous (Rogasch et al., 2013) and our study suggest a 
differential physiological role of early vs. late TEPs which may prove of relevance for the 
interpretation of  TMS-EEG data in a clinical diagnostic setting. 
4.2 Drug effects on LICI 
If our hypothesis is correct that LICI represents GABABergic neurotransmission, then 
baclofen, a specific agonist at the GABABR should increase LICI. Indeed, we found that 
baclofen showed a trend towards enhancement of LICI of the N45 and N100 potentials, and 
significantly enhanced LICI of the P180 potential. Of note, the baclofen effect on LICI of the 
N100 was expressed ipsilateral, whilst the baclofen effect on LICI of the P180 was expressed 
contralateral to the stimulation. The mechanisms of baclofen-induced enhancement of LICI of 
these potentials are not clear, but may involve enhanced GABABergic neurotransmission in 
local inhibitory networks at the site of the stimulation, enhanced local GABABergic control 
of transcallosal inputs to the contralateral hemisphere (Irlbacher et al., 2007; Palmer et al., 
2013), or a cross-talk between GABABRs and GABAARs as recently described within the 
thalamus (Connelly et al., 2013), resulting in disrupted thalamo-cortical communication 
important for propagation of later TEPs from the stimulated to the non-stimulated hemisphere. 
Future studies, including source modeling of TEPs, may help in elucidating the generation, 
propagation and modulation of TEPs by conditioning stimuli, and drugs. 
In contrast, there was no effect of baclofen on LICI of the P25, even though LICI of the 
P25 at baseline (i.e. before drug intake) correlated directly with the amplitude of the N100 
potential in the single-pulse condition [which can be considered as a marker of GABABR-
mediated inhibition (Premoli et al., 2014)], suggesting an underlying GABABR-mediated 
mechanism. The reason for this discrepancy is not clear, but may be due to the low reliability 
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of LICI measurements of the P25 as suggested by a low Cronbach’s alpha-value for test-retest 
reliability (cf. Fig. 2D). Prior TMS-EMG experiments have shown increased LICI under 
baclofen, i.e. baclofen led to a stronger suppression of the test MEP in the presence of CS100 
as compared to the drug-naïve situation (McDonnell et al., 2006; Müller-Dahlhaus et al., 
2008), and it was shown that the P25 can be linked to the MEP amplitude elicited in the target 
muscle (Ferreri et al., 2011; Mäki and Ilmoniemi, 2010). Taken together, these data suggest 
that the P25 may indeed only partially reflect the neural circuits underlying generation of the 
MEP, and point towards an additional spinal GABABergic inhibitory control of the MEP. 
Whatever the exact underlying mechanisms, our findings corroborate the notion that LICI as 
determined by TMS-EEG offers higher selectivity in testing cortical GABABergic 
neurotransmission than can be derived indirectly by TMS-EMG. 
Diazepam consistently suppressed LICI of later potentials (i.e. N100, P180), without 
having an effect on LICI of earlier (i.e. P25, N45 and P70) potentials. In addition, correlation 
analyses showed that the diazepam-induced suppression of LICI of the N100 and P180 
potential was highest in those individuals who showed the strongest LICI of these potentials 
at baseline. These findings again suggest a close link between GABAAR- and GABABR-
mediated control of cortico-cortical (incl. cortico-thalamo-cortical) propagation of TS-evoked 
activity. GABAAR-mediated inhibition has been shown to control excitatory transcallosal 
pathways to contralateral GABAergic interneurons acting through GABABRs (Irlbacher et 
al., 2007; Palmer et al., 2013). Likewise, GABAAR-mediated recurrent inhibition of thalamic 
reticular nucleus cells results in suppression of intrathalamic GABABergic neurotransmission, 
and hence modulation of intrathalamic oscillations important for thalamo-cortical 
communication (Huguenard and Prince, 1994). 
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4.3 Conclusion 
We here demonstrated, for the first time, directly at the system level of the human cortex that 
GABABR-mediated cortical inhibition contributes to LICI. Data further suggest a tight 
control of GABABR-mediated inhibition by GABAAergic neurotransmission. Paired-pulse 
TMS-EEG allows high-resolved characterization of the spatiotemporal dynamics of LICI, 
more directly than hitherto possible with other techniques such as TMS-EMG. Our findings 
provide important evidence on the mechanisms of LICI and help to build a solid basis for 
interpretation of paired-pulse TMS-EEG data in patients with impaired GABAergic cortical 
control such as in schizophrenia or epilepsy (Hasan et al., 2012; Kimiskidis et al., 2014; 
Lewis et al., 2005). 
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